1. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes. (19th May 2019) Authors: Harrison, Paul; Bethel, M. Angelyn; Kennedy, Irene; Dinsdale, Robert; Coleman, Ruth; Holman, Rury R. Journal: Platelets Issue: Volume 30:Number 4(2019) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GW24-e3986 Aspirin given twice daily reduced the platelet reactivity more than once daily in people with type 2 diabetes without cardiovascular disease. (1st October 2013) Authors: YiHong, Sun; Angelyn Bethel, M; Holman, Rury R; Sourij, Harald; Paul Harrison, F; Tucker, Lynne; Kennedy, Irene; White, Sarah; Hill, Lucy; Oulhaj, Abderrahim; Coleman, Ruth; Hu, Dayi Journal: Heart Issue: Volume 99(2013)Supplement 3 Page Start: A249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients. Issue 3 (12th June 2020) Authors: Ballav, Chitrabhanu; Dhere, Archana; Kennedy, Irene; Agbaje, Olorunsola F.; White, Sarah; Franklin, Rachel; Hartmann, Bolette; Holst, Jens J.; Holman, Rury R.; Owen, Katharine R. Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 3(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗